ANIP (ANI Pharmaceuticals, Inc.) Quarterly Revenue Growth

Corporate emblem and logo of anipharmaceuticals.com (ANIP)

The reliability of ANI Pharmaceuticals (ANIP) is based on the supply of branded and generic drugs to US hospital networks. Quarterly revenue dynamics confirm this status, with the value stabilizing at 27.10. High barriers to entry and regulatory oversight protect the business, while the expansion of specialized gel product lines serves as the primary driver for the company's current financial performance.

ANI Pharma (ANIP) - Quarterly Revenue Increase from 07/04/2022 to 11/20/2026

Analytical breakdowns for ANI Pharmaceuticals, Inc. (ANIP)

Analysis of all company metrics:ANIP - ANI Pharmaceuticals
Manufactured products of anipharmaceuticals.com

For ANI Pharmaceuticals (ANIP), quarter-over-quarter revenue growth reflects the effectiveness of drug commercialization while adhering to strict environmental standards for synthesis and waste disposal. This indicator measures the pace of cash flow expansion relative to the previous period, allowing investors to assess the real operational resilience of the business and asset quality by filtering out market volatility through the analysis of actual sales growth.

Competing companies

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|MNKD - Revenue Growth QoQ|Amphastar - Sales Change QoQ|PCRX: Quarterly Revenue Growth|ars-pharma.com - Quarterly Revenue Increase|TBPH (Theravance Biopharma Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)